Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine Eli Lilly and Company
Serwis informacyjny, platforma współpracy grupowej, szkolenia i egzaminy
Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine Eli Lilly and Company
